Buy Cellular Biomedicine Group Stock | CBMG Stock Price & Latest News | Public.com
CBMG

Cellular Biomedicine Group

    Small Market Cap

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Cellular Biomedicine Group (CBMG) stock trends here

    About CBMG

    Cellular Biomedicine Group, Inc. is a holding company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. It specializes in immune cell therapy. The company was founded in 2009 and is...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.29
    -0.59
    -0.88
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.62

    Actual EPS
    Q2 2021

    Stats

    Market Cap$384,14M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$19.75
    1 Year Low$11.48
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app